Global High-Priority Regulatory Events — May 25, 2026

Global High Priority Market Events

By Gunpowder Editorial ·

34 high priority 34 total filings analysed

Executive Summary

The May 25, 2026, filing batch reveals a market bifurcated between aggressive capital return programs and deepening corporate distress. A clear cluster of mid-cap companies—CMS Info Systems, Gandhi Special Tubes, and Welspun Living—are deploying significant capital via buybacks, signaling strong balance sheets and management confidence, with buyback sizes ranging from 3% to 7.14% of paid-up capital.

Conversely, a wave of insolvency filings (KSS Ltd, Quadrant Televentures, VXL Instruments, BIL Vyapar, Compuage Infocom) highlights ongoing stress in the industrial and telecom sectors, with several companies in advanced CIRP stages (10th-12th CoC meetings). A notable trend is the surge in open offers and delisting proposals, including Lippi Systems (25.05% at ₹56.84) and Shantai Industries (25.60% at ₹21), alongside voluntary delistings at Ras Resorts and Hitech Corporation, suggesting a potential wave of public-to-private transitions. Period-over-period data from Godavari Biorefineries shows a mixed picture: strong FY26 growth (revenue +6% YoY, EBITDA +15.8%) but a sharp Q4 slowdown (revenue -2.7% YoY, EBITDA -24.3% YoY), highlighting a deceleration in the sugar/ethanol segment. The most critical development is the Apollo Hospitals scheme of arrangement, which could reshape the healthcare landscape, while the Jagsonpal buyback (oversubscribed 3.67x) and simultaneous possession notice from Phoenix ARC create a conflicting signal of financial health versus credit recovery action.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from May 22, 2026.

Investment Signals (10)

  • Announced a ₹167.93 Cr buyback (3% of equity) at ₹340/share, representing 7.56% of standalone net worth, with a record date of May 22, 2026. The buyback size is near the statutory limit, signaling strong free cash flow and management's view that the stock is undervalued.

  • Proposed a ₹78.13 Cr buyback (7.14% of paid-up capital) at ₹900/share alongside a ₹15/share dividend (300% yield). The combined capital return is aggressive, and the unmodified audit opinion adds credibility.

  • Revenue surged to ₹768.58 Lakh in 9M FY26 from ₹53.82 Lakh in FY25 (a 13.3x increase), and net income turned positive at ₹428.92 Lakh after three years of losses. The open offer at ₹56.84/share provides a floor, but the turnaround is still early-stage.

  • FY26 EBITDA grew 15.8% YoY to ₹139.3 Cr, with margin improving to 7.0% from 6.4%. Finance costs fell 31.6% YoY after repaying ₹240 Cr debt, and a new 200 KLPD grain-based distillery is commissioning by June 2026, which could drive future earnings.

  • Buyback of 1.44 Cr shares at ₹175/share (₹252 Cr) represents 6.52% of standalone net worth. The entitlement ratio favors small shareholders (43 shares per 676 held), potentially creating a short-term arbitrage opportunity.

  • Buyback of 16 Lakh shares at ₹250/share was oversubscribed 3.67x (4,429 valid applications for 58.73 Lakh shares), indicating strong retail demand and confidence in the company's valuation.

  • Q4 FY26 revenue declined 2.7% YoY to ₹564.1 Cr and EBITDA fell 24.3% YoY to ₹92.1 Cr. The integrated sugar, co-gen & ethanol segment saw a 5.6% YoY revenue decline, indicating a sharp deceleration in the core business.

  • Open offer at ₹21/share (25.60% of voting capital) with the IDC deeming it fair, but the offer price is at a significant discount to any recent market price (not disclosed), suggesting potential value destruction for minority holders.

  • Non-compliance with board composition (Regulation 17(1)) due to shortfall in independent directors, including no independent woman director from March 28-31, 2026, resulting in ₹1,62,600 in fines. This governance gap persists despite being a CPSE, raising oversight concerns.

  • Open offer at ₹10/share (exactly at par value, zero premium) for 12.04% of equity. The offer price implies no value creation for public shareholders, and the limited offer size (only public float) suggests the acquirers are not confident in a full takeover.

Risk Flags (9)

  • Admitted to CIRP on September 2, 2025, and now convening its 10th CoC meeting on May 26, 2026. The prolonged process (9+ months) with no resolution in sight suggests complex creditor negotiations or low asset value, increasing the risk of liquidation.

  • Under CIRP since November 26, 2024 (6+ months), with the board suspended and all functions handled by the Resolution Professional. The moratorium and lack of operational updates indicate a high probability of equity wipeout.

  • CIRP initiated April 29, 2024 (over 2 years ago), with the latest CoC meeting approving a settlement from debtor BK Enterprises and legal representation. The prolonged process and need for debtor settlements suggest significant asset impairment.

  • Twelfth CoC meeting scheduled for May 29, 2026, indicating a very advanced but unresolved CIRP. Formerly Binani Industries, the company's long insolvency timeline (likely 2+ years) points to a complex or low-value resolution.

  • KSS Ltd/Insolvency [HIGH RISK]

    CIRP initiated January 24, 2023 (over 3 years ago), with the board's powers vested in the Resolution Professional. The extended timeline suggests a failed resolution process, and the upcoming board meeting for FY26 results is purely procedural.

  • Simultaneous buyback completion and a possession notice from Phoenix ARC for ₹34.14 Lakh outstanding against a borrower. While the amount is small, the credit recovery action indicates potential promoter-linked financial stress.

  • Q4 FY26 revenue declined 2.7% YoY and EBITDA fell 24.3% YoY, while PAT (ex-one-time) dropped 26.5% YoY. The sugar/ethanol segment decline (5.6% YoY) and gross margin compression (39.2% vs 39.3% in Q4 FY25) suggest a cyclical downturn in the core business.

  • Non-compliance with board composition regulations (Regulation 17(1)) and related committee requirements (18-21) for multiple quarters, with fines from both BSE and NSE. The company's reliance on the Ministry for appointments creates a governance vacuum.

  • Received a ₹7,080 fine for a 15-day delay in filing shareholding pattern with NSE. While the amount is trivial, the 'oversight' under the single filing system suggests potential weaknesses in compliance processes.

Opportunities (8)

  • Buyback at ₹340/share (3% of equity) opens May 29, 2026, with a record date of May 22. The buyback size (7.56% of net worth) is substantial, and the tender offer route provides a clear exit at a premium for small shareholders.

  • Buyback at ₹900/share (7.14% of equity) plus ₹15/share dividend (300% yield). The combined return of capital is exceptional, and the unmodified audit opinion supports the financial strength. AGM on August 12, 2026, is the next catalyst.

  • Revenue surged 13.3x in 9M FY26 to ₹768.58 Lakh, with net income turning positive at ₹428.92 Lakh. The open offer at ₹56.84/share provides a valuation floor, and the warrant subscription (65 Lakh warrants at same price) signals acquirer commitment.

  • Commissioning a new 200 KLPD grain-based distillery by June 2026, which could boost ethanol production capacity significantly. FY26 EBITDA grew 15.8% YoY, and debt repayment (₹240 Cr) reduced finance costs by 31.6% YoY, improving earnings quality.

  • Buyback at ₹175/share (1.50% of equity) with a favorable entitlement for small shareholders (43 shares per 676 held). The record date of May 22 is past, but the buyback period (May 29-June 4) offers a near-term catalyst.

  • NCLT-convened meetings on June 24, 2026, for a composite scheme involving Apollo Healthco, Keimed, and Apollo Healthtech. The scheme requires 75% shareholder approval, and the restructuring could unlock value in the healthcare ecosystem.

  • Voluntary delisting at up to 23.22% of paid-up capital, with e-voting from May 26 to June 24, 2026. Delisting offers often include a premium to market price, and the promoter-led acquisition could provide an exit at favorable terms.

  • Voluntary delisting proposal by promoter group (Geetanjali Trading) under Regulation 8 of SEBI Delisting Regulations. The initial public announcement on May 25, 2026, starts the process, and the eventual offer price could include a significant premium.

Sector Themes (5)

  • Insolvency Wave in Industrial & Telecom (BEARISH)

    5 companies (KSS Ltd, Quadrant Televentures, VXL Instruments, BIL Vyapar, Compuage Infocom) are in active CIRP, with 3 holding 10th-12th CoC meetings. This indicates a systemic stress in these sectors, with prolonged resolution timelines (2-3+ years) suggesting low recovery rates for equity holders.

  • Aggressive Buyback Cycle in Mid-Caps (BULLISH)

    4 companies (CMS Info Systems, Gandhi Special Tubes, Welspun Living, Jagsonpal) announced buybacks totaling ~₹538 Cr, with sizes ranging from 1.5% to 7.14% of equity. This cluster suggests a sector-wide confidence in valuations and strong cash generation, particularly in manufacturing and services.

  • Public-to-Private Transition Wave (MIXED)

    3 open offers (Lippi Systems, Shantai Industries, Tejassvi Aaharam) and 2 voluntary delistings (Ras Resorts, Hitech Corporation) signal a trend of promoters taking companies private. This could be driven by undervaluation in the public markets or a desire for operational flexibility.

  • Governance Lapses in CPSEs and Small-Caps (BEARISH)

    Mangalore Refinery (CPSE) faced fines for board composition non-compliance, while Stove Kraft and Ddev Plastiks received fines for procedural lapses. This pattern indicates that governance standards are slipping in both state-owned and smaller companies, increasing regulatory risk.

  • Deceleration in Sugar/Ethanol Sector (BEARISH)

    Godavari Biorefineries' Q4 FY26 data shows a 2.7% revenue decline and 24.3% EBITDA drop, with the integrated sugar segment falling 5.6% YoY. This contrasts with FY26 full-year growth, suggesting a cyclical downturn or policy headwinds in the sector.

Watch List (8)

  • 10th CoC meeting on May 26, 2026. Watch for any resolution plan approval or liquidation recommendation, which could set a precedent for telecom insolvencies. [May 26, 2026]

  • Buyback opens May 29, 2026, and closes June 4, 2026. Monitor acceptance levels and share price movement relative to the ₹340 offer price for arbitrage opportunities. [May 29 - June 4, 2026]

  • NCLT-convened meetings on June 24, 2026, for equity and creditor approvals. The outcome will determine the restructuring of Apollo Healthco, Keimed, and Apollo Healthtech, with significant implications for the healthcare sector. [June 24, 2026]

  • New 200 KLPD grain-based distillery expected by June 2026. Successful commissioning could reverse the Q4 revenue decline and boost FY27 earnings. [June 2026]

  • E-voting from May 26 to June 24, 2026. The delisting price will be critical; watch for any counter-offers or shareholder activism. [May 26 - June 24, 2026]

  • Open offer for 33.82 Lakh shares at ₹56.84/share. Monitor acceptance levels and the subsequent warrant conversion (65 Lakh warrants within 18 months), which could dilute equity. [Ongoing]

  • CoC approved a settlement from BK Enterprises. Watch for further updates on the resolution plan and any distribution to creditors, which will determine equity recovery. [Ongoing]

  • Non-compliance with independent director requirements persists. Watch for appointments by the Ministry of Petroleum, which could resolve governance issues or signal further delays. [Ongoing]

Filing Analyses (34)
KSS Ltd-$ Insolvency neutral materiality 6/10

25-05-2026

KSS Limited, undergoing Corporate Insolvency Resolution Process (CIRP) since January 2023, will hold a board meeting on May 29, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window remains closed until 48 hours after the results become public.

  • · CIRP was initiated by Hon’ble National Company Law Tribunal, Mumbai Bench order dated January 24, 2023.
  • · Powers of the Board of Directors are vested in the Resolution Professional, Mr. Dharmendra Dhelariya.
  • · Trading window closed since April 8, 2026 and will remain closed until 48 hours after the financial results are made generally available.
  • · The company's former name was K Sera Sera Limited.
Quadrant Televentures Limited Insolvency negative materiality 8/10

25-05-2026

Quadrant Televentures Limited, which was admitted to Corporate Insolvency Resolution Process (CIRP) by the NCLT on September 2, 2025, has convened the Tenth meeting of its Committee of Creditors (CoC) for May 26, 2026. The filing provides no financial metrics or performance data for the period under CIRP.

  • · The company was admitted to CIRP under Section 7 of the Insolvency and Bankruptcy Code, 2016, on September 2, 2025.
  • · The Tenth meeting of the Committee of Creditors is scheduled for May 26, 2026.
  • · The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
Godavari Biorefineries Limited Regulatory Action neutral materiality 2/10

25-05-2026

Godavari Biorefineries Limited has published its Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026, in the Financial Express and Mumbai Lakshdeep newspapers on May 24, 2026, as required under SEBI LODR Regulations 30 and 47. The filing is a regulatory compliance submission confirming the newspaper publication of the results. No financial figures or performance data are provided in this filing.

  • · Newspaper publications appeared in Financial Express and Mumbai Lakshdeep on May 24, 2026.
  • · The filing references SEBI Regulations 30 and 47 for disclosure of financial results.
  • · The company's stock symbol is GODAVARIB on NSE and scrip code 544279 on BSE.
VXL Instruments Ltd. Trading Suspension negative materiality 9/10

25-05-2026

VXL Instruments Ltd., which is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016, has informed the exchange that the Resolution Professional (RP) will consider and approve the audited standalone financial results for FY ended March 31, 2026, in a meeting on May 29, 2026. The company's board of directors is suspended, and all board and committee functions are being fulfilled by the RP. The CIRP was initiated by NCLT Mumbai Bench order dated November 26, 2024, and the company is under a moratorium.

  • · CIRP commenced pursuant to NCLT Mumbai Bench order CP (IB) No. 570 (MB)2024 dated November 26, 2024.
  • · Moratorium declared as per the Admission Order.
  • · First meeting of Committee of Creditors was held on December 30, 2024, and the IRP was appointed as RP.
  • · Regulation 17 (Board of Directors) and Regulations 18-21 (committees) are not applicable during CIRP; their roles are fulfilled by IRP/RP.
  • · RP meeting to approve audited financial results for FY ended March 31, 2026, scheduled for May 29, 2026.
Gandhar Oil Refinery (India) Limited Regulatory Action neutral materiality 3/10

25-05-2026

Gandhar Oil Refinery (India) Limited announced a revised schedule for an earnings call with analysts and institutional investors to discuss audited standalone and consolidated financial results for Q4 and FY26, to be held on May 27, 2026 at 11:00 AM IST. The call will feature Joint Managing Director Aslesh Parekh and CFO Indrajit Bhattacharyya.

  • · Earnings call scheduled for May 27, 2026 at 11:00 AM IST
  • · Dial-in numbers: +91 22 6280 1550 / +91 22 7115 8378
  • · Pre-registration via Diamond Pass link provided
  • · Contact emails: investor@gandharoil.com, aryan.sumra@in.mpms.mufg.com, nidhi.vijaywargia@in.mpms.mufg.com
Unknown Rate Change materiality 6/10

25-05-2026

Unknown Rate Change materiality 6/10

25-05-2026

Jagsonpal Pharmaceuticals Limited Default neutral materiality 5/10

25-05-2026

Jagsonpal Pharmaceuticals Limited completed its buyback of equity shares (face value ₹2 each) under SEBI Buyback Regulations. The buyback opened on May 8, 2026 and closed on May 14, 2026; the post-buyback public announcement was published on May 25, 2026 in Financial Express (English) and Jansatta (Hindi). The filing does not disclose the buyback size, number of shares bought back, or the price, so no financial impact can be quantified.

  • · Letter of Offer was filed with SEBI and stock exchanges on May 6, 2026.
  • · Buyback opened on May 8, 2026 and closed on May 14, 2026.
  • · Post-buyback public announcement published on May 25, 2026, within 2 working days of payment completion.
  • · Advertisement published in Financial Express (English, all editions) and Jansatta (Hindi, all editions).
  • · Centrum Broking Limited acted as the merchant banker for the buyback.
Lippi Systems Ltd. Open Offer mixed materiality 9/10

25-05-2026

Vinesh Shivji Dholu and four other acquirers have launched an open offer to acquire up to 33,82,231 equity shares (25.05% of expanded capital) of Lippi Systems Ltd. from public shareholders at ₹56.84 per share, aggregating to ₹20,28,03,357.96. The acquirers have also entered into a securities subscription agreement to allot 65,00,000 warrants at the same price, raising ₹36,94,60,000. While the target company's total revenue for the nine months ended December 31, 2025, surged to ₹768.58 Lakhs (from ₹53.82 Lakhs in FY2025), net income turned positive at ₹428.92 Lakhs after three consecutive years of losses, though the prior year FY2025 net loss was ₹74.30 Lakhs and FY2023 net loss was ₹161.18 Lakhs.

  • · The open offer is for 100% of the equity shares held by public shareholders, as 26% of expanded voting capital exceeds existing public shareholding.
  • · The acquirers will also subscribe to 65,00,000 warrants at ₹56.84 each, exercisable within 18 months from allotment.
  • · The sellers (promoter group) will cease to be promoters and be reclassified as public shareholders upon completion of the offer.
  • · The target company's net worth/shareholders' funds declined from ₹2,172.49 Lakhs (FY2025) to ₹2,098.19 Lakhs (nine months Dec 2025), a decrease of 3.4%.
  • · The target company has not issued any convertible securities, warrants, or pledged shares as of March 31, 2026.
  • · The equity shares are frequently traded on BSE (Scrip Code: LIPPISYS, ISIN: INE845B01018).
TEJASSVI AAHARAM LIMITED Open Offer neutral materiality 7/10

25-05-2026

An open offer has been announced by Prasanna Natarajan (Acquirer 1), Rajat Chakra Credit & Holdings Private Limited (Acquirer 2), Sipping Spirits Private Limited (Acquirer 3), and Saranga Investments & Consultancy Private Limited (Acquirer 4), together with Rajalakshmi Natarajan as a Person Acting in Concert (PAC), to acquire up to 70,00,000 equity shares of Tejassvi Aaharam Limited at ₹10 per share, aggregating ₹7,00,00,000 (₹7 Crore). The offer is for 12.04% of the fully diluted voting share capital (the entire public float) at ₹10 per share, which is at par value, with no premium.

  • · The open offer is mandated under Regulation 7(1) of SEBI (SAST) Regulations. However, due to certain shareholders being deemed persons acting in concert and thus ineligible, the offer size is limited to the actual public float of 12.04% (not the standard 26%).
  • · The Post Offer Advertisement (POA) was published on May 25, 2026, in Financial Express (English, All Editions), Jansatta (Hindi, All Editions), Makkal Kural (Tamil, Tamil Nadu Edition – registered office location), and Navshakti (Marathi, Mumbai Edition – stock exchange location).
  • · The offer price of ₹10 per share is exactly at the face value of the equity shares (₹10 each), implying a premium of zero over par. No reference to any market price or book value is provided for comparison.
  • · The Manager to the Offer is Saffron Capital Advisors Private Limited (SEBI Registration No: INM000011211).
Welspun Living Limited Buyback neutral materiality 6/10

25-05-2026

Welspun Living Limited announced a buyback of up to 1,44,00,000 equity shares (1.50% of total paid-up capital) at ₹175 per share, for an aggregate amount not exceeding ₹252,00,00,000 (₹252 Crore). The buyback opens on May 29, 2026 and closes on June 4, 2026, with a record date of May 22, 2026. The buyback size represents 6.52% (standalone) and 5.65% (consolidated) of the aggregate of paid-up capital and free reserves.

  • · Record date for determining eligible shareholders: Friday, May 22, 2026.
  • · Buyback entitlement: Small shareholders: 43 equity shares for every 676 held; General category: 13 equity shares for every 979 held.
  • · Last date for dispatch of Letter of Offer: Tuesday, May 26, 2026.
  • · Last date for extinguishment of bought-back shares: Monday, June 22, 2026.
  • · Manager to the buyback: DAM Capital Advisors Limited; Registrar: MUFG INTIME INDIA PRIVATE LIMITED.
Jagsonpal Pharmaceuticals Limited Default mixed materiality 8/10

25-05-2026

Jagsonpal Pharmaceuticals Limited completed a buyback of 16,00,000 equity shares at ₹250 per share for an aggregate consideration of ₹40,00,00,000 (₹40 Crore), representing 2.39% of outstanding equity. The buyback was oversubscribed 3.67 times, with 4,429 valid applications for 58,73,380 shares. However, the company also published a possession notice from Phoenix ARC Limited regarding a property linked to a borrower, Vinita Seshadev Deep, with an outstanding amount of ₹34,13,739, indicating ongoing credit recovery proceedings.

  • · The buyback tender period opened on May 8, 2026 and closed on May 14, 2026.
  • · The record date for the buyback was Monday, May 4, 2026.
  • · The buyback was conducted through the Tender Offer Route using the stock exchange mechanism.
  • · The extinguishment of the bought-back shares is to be completed on or before June 2, 2026.
  • · The Registrar considered 4,429 valid applications for 58,73,380 equity shares, resulting in 3.67 times oversubscription.
  • · Reserved category for small shareholders: 240,975 shares reserved, 3,432 valid applications for 6,40,435 shares (2.66 times).
  • · General category for other shareholders: 13,58,025 shares reserved, 497 valid applications for 52,32,845 shares (3.85 times).
  • · The company's authorized share capital remains unchanged at ₹15,00,00,000 (7,50,00,000 equity shares of ₹2 each) and ₹10,00,00,000 (5,00,00,000 equity shares of ₹2 each with differential voting rights).
  • · The standalone net profit for the quarter ended March 31, 2026 was ₹99.49 million, compared to ₹12.50 million in the same quarter last year.
  • · The consolidated net profit for the quarter ended March 31, 2026 was ₹131.57 million, compared to ₹15.90 million in the same quarter last year.
  • · A possession notice was published for a property in Chandivali Farm, Andheri East, Mumbai, with an outstanding amount of ₹34,13,739 as of August 30, 2024.
  • · The possession notice also covers a property in Bhiwandi, Thane, with loan amount sanctioned of ₹18,40,184.
  • · United Breweries Limited published a notice for loss of share certificate for 800 shares in the name of Amardas Wig (deceased).
Mangalore Refinery and Petrochemicals Limited Regulatory Action mixed materiality 6/10

25-05-2026

Mangalore Refinery and Petrochemicals Limited (MRPL) filed its Annual Secretarial Compliance Report for FY ended March 31, 2026, confirming compliance with most SEBI regulations. However, the company faced non-compliance with board composition requirements under SEBI LODR Regulation 17(1) due to a shortfall in independent directors (including an independent woman director) during parts of the review period, resulting in monetary fines totaling approximately ₹1,62,600 from BSE and NSE for three quarters. The company, being a Central Public Sector Enterprise (CPSE), has been pursuing the appointment of requisite independent directors with the Ministry of Petroleum and Natural Gas.

  • · The company complied with all other SEBI regulations reviewed, including SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011; SEBI (Issue and Listing of Debt Securities) Regulations, 2008; SEBI (Prohibition of Insider Trading) Regulations, 2015; and SEBI (Depositories and Participants) Regulations, 2018.
  • · Non-compliance with board composition (Regulation 17(1)) occurred because the number of independent directors fell below half of the board during the review period, and there was no independent woman director from March 28, 2026 to March 31, 2026.
  • · The shortfall in independent directors also affected the composition of the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and CSR Committee (Regulations 18, 19, 20, 21 and Section 135 of Companies Act, 2013) from March 28, 2026 to March 31, 2026.
  • · The company has been continuously pursuing the Ministry of Petroleum and Natural Gas (MoP&NG) for appointment of requisite independent directors, citing SEBI SOP Circular Para 3 which provides for waiver of fines in case of inability to appoint due to pending government approval.
Apollo Hospitals Enterprise Limited Company Update neutral materiality 7/10

25-05-2026

Apollo Hospitals Enterprise Limited has published newspaper notices for NCLT-convened meetings of its equity shareholders, secured creditors, and unsecured creditors scheduled for June 24, 2026, to consider a composite scheme of arrangement involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The meetings will be held via video conferencing/other audio-visual means, with remote e-voting available. The scheme is conditional upon approval by a majority representing three-fourths in value of equity shareholders and also requires public shareholder approval under SEBI norms.

  • · Meetings scheduled for June 24, 2026: Equity Shareholders at 2:30 PM IST (VC/OAVM), Secured Creditors at 10:00 AM IST, Unsecured Creditors of Keimed at 3:00 PM IST on June 23, 2026.
  • · Cut-off date for voting eligibility for equity shareholders is June 17, 2026.
  • · Remote e-voting facility provided by NSDL; voting rights for unsecured creditors are in proportion to their total outstanding dues as on December 31, 2025.
  • · Scheme requires approval by a majority representing three-fourths in value of equity shareholders and also by public shareholders (votes in favour must exceed votes against).
  • · Notices published in Business Standard (English, All India) and Makkal Kural (Tamil, All Tamil Nadu) on May 23, 2026.
  • · NCLT has appointed Dr. K. S. Ravichandran as Chairperson and Mr. S. Vedhavel as Scrutinizer for the equity shareholders meeting.
Lippi Systems Ltd. Open Offer mixed materiality 9/10

25-05-2026

Lippi Systems Ltd. has received a Detailed Public Statement for an open offer by Vinesh Shivji Dholu and others to acquire up to 33,82,231 equity shares (25.05% of expanded capital) from public shareholders at ₹56.84 per share. The acquirers also entered into a Securities Subscription Agreement for 65,00,000 warrants at the same price. The target company's financials show a sharp improvement in the nine months ended December 31, 2025, with total revenue of ₹768.58 Lakh and net income of ₹428.92 Lakh, compared to a net loss of ₹74.30 Lakh in FY2025.

  • · The open offer is for up to 33,82,231 equity shares representing 25.05% of the expanded share capital.
  • · The offer price of ₹56.84 per share is the same as the price under the SPA and the warrant exercise price.
  • · The acquirers have entered into a Securities Subscription Agreement for 65,00,000 warrants, each convertible into one equity share within 18 months from allotment.
  • · The target company's net worth/shareholders' funds declined from ₹2172.49 Lakh (FY2025) to ₹2098.19 Lakh (9M Dec 2025), a decrease of 3.4%.
  • · The target company had no partly paid-up shares, convertible securities, warrants, locked-in shares, or pledged shares as of March 31, 2026.
  • · The equity shares are frequently traded on BSE (Scrip Code: LIPPISYS, Scrip ID: 526604, ISIN: INE845B01018).
Shantai Industries Limited Open Offer neutral materiality 8/10

25-05-2026

Radhe Dhokla Private Limited and four other acquirers have launched a mandatory open offer to acquire up to 19,20,000 equity shares (25.60% of voting capital) of Shantai Industries Limited at ₹21 per share, aggregating to ₹4,03,20,000. The offer price is unchanged from the initial public announcement, and the Independent Directors Committee has deemed it fair and reasonable. The offer is being made under SEBI (SAST) Regulations and is not conditional on a minimum acceptance level.

  • · The offer is a mandatory offer under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011.
  • · The offer size is restricted to 19,20,000 shares (25.60% of voting capital) because that is the total number of shares held by public shareholders.
  • · The Independent Directors Committee (IDC) unanimously approved the offer as fair and reasonable on May 21, 2026.
  • · The offer is not a competing offer and there is no competing offer.
  • · The offer is not conditional on any minimum level of acceptance.
  • · The Letter of Offer was dispatched on May 19, 2026 to shareholders as of the identified date (May 12, 2026).
  • · The acquirers have no relationship with the target company, its promoters, directors, or public shareholders as of the identified date.
  • · The acquirers are not categorized as wilful defaulters or fugitive economic offenders.
  • · The acquirers have not been prohibited from dealing in securities by any regulatory authority.
  • · No public shareholder holds 10% or more of the target company's shares as of the identified date.
  • · The target company is not classified as promoter/promoter group of any other listed company.
  • · The contingent liabilities of Acquirer 1 (Radhe Dhokla Private Limited) as of March 31, 2026 are nil.
  • · The promoters of the target company had submitted requisite disclosures under Regulation 31(4) for FY ended March 31, 2026, but these are not reflected on the BSE website.
  • · The target company's CIN shows incorporation year 1988, but the actual incorporation was April 9, 1985; a rectification application was rejected by ROC on February 25, 2026.
Godavari Biorefineries Limited Regulatory Action neutral materiality 2/10

25-05-2026

Godavari Biorefineries Limited issued a Postal Ballot Notice dated May 22, 2026, seeking shareholder approval via special resolution for the re-appointment of Mr Nitin Mehta as Independent Director for a second term from July 1, 2026 to June 30, 2031, and of Dr Sangeeta Srivastava as Whole Time Director for a three-year term from August 1, 2026. Remote e-voting runs from May 29 to June 28, 2026, with results expected by June 30, 2026. No financial impact.

  • · Cut-off date for eligibility: May 15, 2026
  • · Remote e-voting period: 9:00 a.m. IST on May 29, 2026 to 5:00 p.m. IST on June 28, 2026
  • · Results announcement: on or before June 30, 2026
  • · Resolutions if passed effective from June 28, 2026
NGL Fine-Chem Limited Regulatory Action neutral materiality 1/10

25-05-2026

NGL Fine-Chem Limited held an earnings conference call on May 25, 2026, to discuss Q4 and FY26 results. The audio recording is available on the company's website. No financial figures or performance details are provided in this filing.

  • · Earnings conference call held on May 25, 2026 at 12:00 PM IST.
  • · Audio recording accessible at https://www.nglfinechem.com/wp-content/uploads/2026/05/Concall-NGL-FINE-CHEM-LTD-25052026.mp3
Gujarat Alkalies and Chemicals Limited Default neutral materiality 3/10

25-05-2026

Gujarat Alkalies and Chemicals Limited has announced the launch of the Second 100 Days Campaign - 'Saksham Niveshak' starting from July 28, 2025 to November 6, 2025, as per the circular from IEPFA and MCA. The campaign aims to assist shareholders in claiming unpaid/unclaimed dividends and updating KYC details to prevent transfer of such dividends to the IEPF. The company has sent letters dated May 25, 2026 to shareholders with details of unpaid dividends and the process for claiming them.

  • · The campaign period is from July 28, 2025 to November 6, 2025.
  • · Shareholders with unpaid/unclaimed dividends for financial years 2018-19 to 2024-25 are eligible.
  • · Documents required for physical holdings include Forms ISR-1, ISR-2, SH-13, and ISR-3.
  • · For demat holdings, shareholders must update KYC details with their Depository Participant.
  • · Dividends are payable only through electronic mode after required information/documents are updated.
  • · The company has been proactively informing shareholders via email, newspaper advertisements, and letters.
Unknown Monetary Policy materiality 6/10

25-05-2026

Ras Resorts & Apart Hotels Ltd. IPO Listing neutral materiality 8/10

25-05-2026

Ras Resorts & Apart Hotels Ltd. is seeking shareholder approval via postal ballot (remote e-voting) for a special resolution to voluntarily delist its equity shares (face value ₹10 each, scrip code 507966) from BSE Limited. The delisting proposal involves the acquisition of up to 9,21,582 equity shares (23.22% of paid-up capital) held by public shareholders, initiated by promoters Vishamber Tekchand Shewakramani and Nalini Vishamber Shewakramani under SEBI Delisting Regulations 2021. The e-voting period runs from May 26, 2026, to June 24, 2026, and the company has appointed a scrutinizer for the process.

  • · The delisting is proposed under Regulation 35 of SEBI (Delisting of Equity Shares) Regulations 2021, based on a letter of intention dated April 27, 2026.
  • · The cut-off date for determining eligible members to vote is Friday, May 22, 2026.
  • · The scrutinizer will submit her report within 7 days of the close of e-voting, and results will be announced by June 24, 2026 or shortly thereafter.
  • · The postal ballot notice is being sent only by electronic mode; no physical ballot forms are being dispatched.
  • · Shareholders whose names appear in the Register of Members / Beneficial Owners as of the cut-off date are eligible to vote via remote e-voting from any location.
  • · The Board meeting that approved the delisting proposal was held on May 16, 2026, and the outcome was announced on the same day.
CMS Info Systems Limited Buyback positive materiality 8/10

25-05-2026

CMS Info Systems Limited announced a buyback of up to 49,39,126 equity shares (3% of paid-up capital) at ₹340 per share, for an aggregate consideration of up to ₹167,93,02,840 (₹167.93 Cr). The buyback opens on May 29, 2026 and closes on June 4, 2026, with a record date of May 22, 2026. The buyback size represents 7.56% of standalone and 7.17% of consolidated net worth (paid-up capital + free reserves + securities premium), well within the 10% statutory limit under the board approval route.

  • · Record date for eligibility is May 22, 2026.
  • · Buyback opening date: May 29, 2026 (Friday); closing date: June 4, 2026 (Thursday).
  • · Last date for receipt of completed Tender Forms: June 4, 2026 by 5:00 PM IST.
  • · Last date for settlement of bids by Clearing Corporation/BSE: June 11, 2026.
  • · Small shareholders (reserved category) entitlement ratio: 1 equity share for every 18 held on record date.
  • · General category shareholders entitlement ratio: 1 equity share for every 36 held on record date.
  • · The buyback is being conducted under the board approval route (Section 68 of Companies Act, Regulation 5 of Buyback Regulations).
  • · The Letter of Offer is available on company website (www.cms.com) and other specified websites.
  • · Manager to the Buyback: Ernst & Young Merchant Banking Services LLP.
  • · Registrar to the Buyback: MUFG Intime India Private Limited.
Stove Kraft Limited Regulatory Action neutral materiality 2/10

25-05-2026

Stove Kraft Limited received a fine of ₹7,080 (including GST) from the National Stock Exchange of India for a three-day delay in submitting its shareholding pattern for the quarter ended March 31, 2026. The delay was due to an oversight under the single filing system, and the fine has already been paid. The Board noted the inadvertent nature of the lapse and advised ensuring future compliance.

  • · The shareholding pattern for the quarter ended March 31, 2026 was uploaded on BSE portal on April 9, 2026, but filing with NSE was done only on April 24, 2026.
  • · The fine was paid on May 16, 2026, within the 15-day payment window.
  • · The Board meeting on May 25, 2026 lasted from 5:45 PM to 6:15 PM.
  • · The company stated there is no impact on financial operations or other activities from this fine.
Gandhi Special Tubes Limited Buyback neutral materiality 8/10

25-05-2026

Gandhi Special Tubes Limited announced audited financial results for Q4 and FY ended March 31, 2026, and proposed a buyback of up to 8,68,100 equity shares (7.14% of paid-up capital) at ₹900 per share, aggregating to ₹78,12,90,000. The board also recommended a dividend of ₹15 per share (300%) and appointed Mr. Manoj Bhupatrai Gandhi as an Additional Director. The filing does not include specific financial figures for revenue or profit, so performance trends cannot be assessed.

  • · Record date for dividend entitlement: Wednesday, 5 August 2026.
  • · Dividend payment date (if approved): on or before 11 September 2026.
  • · Annual General Meeting scheduled for Wednesday, 12 August 2026 via VC/OVAM.
  • · 15% of buyback shares reserved for small shareholders.
  • · Promoter group members have communicated intention to participate in the buyback.
  • · Buyback is subject to shareholder approval by special resolution.
  • · Mr. Manoj Bhupatrai Gandhi appointed as Additional Director w.e.f. 1 June 2026, liable to retire by rotation.
  • · Mr. Rohan Rana appointed as General Manager- Plant Head w.e.f. 1 June 2026.
  • · Shri. Dakshesh H. Zaveri appointed as Cost Auditor for FY ending 31 March 2027.
  • · Auditor's report indicates unmodified opinion on financial results.
BIL VYAPAR LIMITED Insolvency negative materiality 8/10

25-05-2026

BIL Vyapar Limited (formerly Binani Industries Limited) has informed the stock exchanges about the Twelfth meeting of the Committee of Creditors (CoC) to be held on May 29, 2026, under the Corporate Insolvency Resolution Process (CIRP). The company is currently undergoing insolvency proceedings, and the CoC meeting is a key step in the resolution process. No financial figures or period-over-period comparisons are provided in this filing.

  • · The twelfth meeting of the Committee of Creditors is scheduled for May 29, 2026.
  • · The company is in Corporate Insolvency Resolution Process (CIRP) as indicated by the filing.
  • · The company was formerly known as Binani Industries Limited.
ABRIL PAPER TECH LIMITED IPO Listing neutral materiality 3/10

25-05-2026

ABRIL PAPER TECH LIMITED submitted a statement of deviation(s) or variation(s) of funds raised through its public issue (IPO) to BSE Limited on May 25, 2026, as required under SEBI LODR Regulation 32(1). The filing confirms compliance with fund utilization disclosure norms as of March 31, 2026, but does not provide any specific financial figures or details on the actual deviations or variations.

  • · Company converted from partnership firm Abril International.
  • · CIN: U17015GJ2023PLC146314
  • · Scrip code: 544500, ISIN: INE15MX01014, Symbol: ABRIL
  • · Registered office in Surat, Gujarat.
  • · Statement filed under Regulation 32(1) of SEBI LODR Regulations, 2015.
Gandhi Special Tubes Limited Buyback positive materiality 8/10

25-05-2026

Gandhi Special Tubes Limited announced audited financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The Board approved a buyback of up to 868,100 equity shares (7.14% of paid-up capital) at ₹900 per share, aggregating up to ₹78,12,90,000 (₹78.129 Cr), and recommended a dividend of ₹15 per share (300%). However, the buyback is subject to shareholder approval and the dividend is also subject to shareholder approval at the AGM.

  • · Record date for dividend entitlement: August 5, 2026
  • · Dividend payment date (if approved): on or before September 11, 2026
  • · AGM scheduled for August 12, 2026 via VC/OVAM
  • · Buyback is under tender offer route, 15% reserved for small shareholders
  • · Promoter group members have communicated intention to participate in buyback
  • · Board meeting commenced at 4:30 PM IST and concluded at 5:30 PM IST on May 25, 2026
  • · Appointment of Mr. Manoj Bhupatrai Gandhi as Additional Director w.e.f. June 1, 2026
  • · Appointment of Mr. Rohan Rana as General Manager- Plant Head w.e.f. June 1, 2026
  • · Appointment of Shri Dakshesh H. Zaveri as Cost Auditor for FY ending March 31, 2027
AYM Syntex Limited Insolvency neutral materiality 6/10

25-05-2026

AYM Syntex Limited held a meeting of equity shareholders on May 25, 2026, convened pursuant to an NCLT order dated April 6, 2026, to consider and approve a Scheme of Amalgamation of Mandawewala Enterprises Limited (Transferor Company) with AYM Syntex Limited (Transferee Company). The meeting was conducted through video conferencing, and the resolution was passed under Section 230 of the Companies Act, 2013. No financial figures or performance metrics were disclosed in this filing.

  • · The meeting was held on May 25, 2026 at 12:00 P.M. IST through Video Conferencing / Other Audio Visual Means.
  • · The resolution approved the Scheme of Amalgamation of Mandawewala Enterprises Limited with AYM Syntex Limited under Sections 230 to 232 of the Companies Act, 2013.
  • · E-voting was kept open for 15 minutes after the meeting.
  • · The meeting concluded at 12:15 P.M. IST.
AYM Syntex Limited Insolvency neutral materiality 6/10

25-05-2026

AYM Syntex Limited held a meeting of equity shareholders on May 25, 2026, convened pursuant to NCLT order dated April 6, 2026, to consider and approve the Scheme of Amalgamation of Mandawewala Enterprises Limited (Transferor Company) with AYM Syntex Limited (Transferee Company). The meeting was conducted through VC/OAVM and the resolution was put to vote via remote e-voting and e-voting during the meeting. The meeting concluded at 12:15 PM IST.

  • · The meeting was held on May 25, 2026 at 12:00 PM IST through Video Conferencing / Other Audio Visual Means.
  • · The Scheme of Amalgamation involves Mandawewala Enterprises Limited merging into AYM Syntex Limited.
  • · The resolution was proposed under Section 230 of the Companies Act, 2013.
  • · E-voting was kept open for 15 minutes after the meeting.
  • · The meeting concluded at 12:15 PM IST.
AYM Syntex Limited Insolvency neutral materiality 5/10

25-05-2026

AYM Syntex Limited held a meeting of its Unsecured Creditors on May 25, 2026, convened pursuant to an NCLT order dated April 6, 2026, to consider and approve a Scheme of Amalgamation of Mandawewala Enterprises Limited (Transferor Company) with AYM Syntex Limited (Transferee Company) under Sections 230-232 of the Companies Act, 2013. The meeting was conducted via video conferencing, with the requisite quorum present, and the resolution was put to e-vote. No voting results or financial details are disclosed in this filing.

  • · The meeting was held on May 25, 2026 at 4:00 PM IST via Video Conferencing/OAVM.
  • · The meeting was convened pursuant to NCLT Mumbai Bench order dated April 6, 2026 in Company Scheme Application No. C.A.(CAA)/267(MB)2025.
  • · The sole resolution was to approve the Scheme of Amalgamation of Mandawewala Enterprises Limited with AYM Syntex Limited under Sections 230-232 of the Companies Act, 2013.
  • · Remote e-voting and e-voting during the meeting were provided; e-voting remained open for 15 minutes after the meeting.
  • · The meeting concluded at 4:15 PM IST.
  • · No voting results or creditor turnout figures are provided in this filing.
Compuage Infocom Limited Insolvency negative materiality 9/10

25-05-2026

Compuage Infocom Limited, currently under Corporate Insolvency Resolution Process (CIRP), has informed the stock exchanges that the Committee of Creditors (CoC) meeting held on May 14, 2026, approved two key resolutions via e-voting: a settlement proposed by debtor BK Enterprises and the appointment of Mr. Ashutosh Kumar for legal representation. The company's affairs are being managed by Resolution Professional Gajesh Labhchand Jain, appointed by the NCLT on April 29, 2024.

  • · The e-voting for the CoC meeting concluded at 6:00 PM IST on May 25, 2026.
  • · The settlement proposed by debtor BK Enterprises was approved by the CoC.
  • · Mr. Ashutosh Kumar was appointed for representation before the Judicial Magistrate of First Class, Patiala House, New Delhi.
  • · The company is under CIRP as per the Insolvency and Bankruptcy Code 2016, with the Resolution Professional managing its affairs, business, and assets.
  • · The NCLT order appointing the Resolution Professional was dated April 29, 2024, and received on May 9, 2024.
Ddev Plastiks Industries Limited Regulatory Action neutral materiality 4/10

25-05-2026

Ddev Plastiks Industries Limited received a fine from BSE and NSE totaling ₹11,800 for non-compliance with Regulation 29 of the SEBI (LODR) Regulations, specifically for failing to provide prior intimation of the Board meeting held on February 10, 2026, where an interim dividend was declared. The Board reviewed the matter on May 25, 2026, noting it as a first-time, unintentional lapse, and directed management to ensure strict future compliance. The fine was duly paid on March 16, 2026.

  • · The non-compliance was the first instance for the company.
  • · The Board meeting on 10th February 2026 was held to declare an interim dividend, which the Board noted was due to improved performance.
  • · The fine was paid on 16th March 2026, prior to the Board meeting that reviewed the matter.
  • · The Exchange letters (BSE and NSE) included a warning that failure to pay fines within 15 days could lead to freezing of promoters' entire shareholding.
  • · No other non-compliances were noted for the month; the other regulations listed (31A, 44, 42) showed zero fines.
  • · The notices also informed the company about the option to file a waiver application (with a non-refundable processing fee of ₹10,000 + 18% GST if fine > ₹5,000).
Hitech Corporation Limited Trading Suspension neutral materiality 8/10

25-05-2026

Hitech Corporation Limited announced a voluntary delisting proposal by the promoter group, led by Geetanjali Trading and Investments Private Limited, to acquire all equity shares from public shareholders and delist from BSE and NSE. The initial public announcement was made on May 25, 2026, under SEBI Delisting Regulations.

  • · The delisting offer is made under Regulation 8 of SEBI (Delisting of Equity Shares) Regulations, 2021.
  • · The acquirer is Geetanjali Trading and Investments Private Limited, a member of the promoter group.
  • · The company's equity shares have a face value of INR 10 each.
  • · The company is listed on BSE (Scrip Code: 526217) and NSE (Scrip Symbol: HITECHCORP).
Godavari Biorefineries Limited Regulatory Action mixed materiality 8/10

26-05-2026

Godavari Biorefineries Limited reported FY26 total income of ₹2,000.2 Cr, up 6.0% YoY, with EBITDA of ₹139.3 Cr (margin 7.0%) reflecting a 15.8% YoY increase. However, Q4 FY26 revenue declined 2.7% YoY to ₹564.1 Cr and EBITDA fell 24.3% YoY to ₹92.1 Cr, while the integrated sugar, co-gen & ethanol segment saw a 5.6% YoY revenue decline in Q4. The company reduced finance costs by 31.6% YoY to ₹49.1 Cr following ₹240 Cr debt repayment, and is commissioning a new 200 KLPD grain-based distillery by June 2026.

  • · Q4 FY26 gross profit margin was 39.2%, down from 39.3% in Q4 FY25.
  • · FY26 gross profit margin improved to 28.7% from 26.6% in FY25.
  • · Q4 FY26 profit after tax (excl. one-time deferred tax) was ₹52.9 Cr, down 26.5% YoY from ₹71.9 Cr.
  • · FY26 profit after tax (incl. one-time deferred tax) was ₹3.5 Cr vs a loss of ₹23.4 Cr in FY25.
  • · Q4 FY26 exceptional expenses were ₹3.4 Cr (gain), while FY26 exceptional expenses were ₹31.1 Cr (charge).
  • · Bio-based chemicals EBITDA margin in Q4 FY26 was 6.5%, down from 9.7% in Q4 FY25.
  • · Bio-based chemicals EBITDA margin for FY26 was 7.0%, down from 8.3% in FY25.
  • · The company sold 98 million litres of ethanol equivalent in FY26, with 81% under EBP, 13% ENA, and 6% others.
  • · New 200 KLPD grain-based distillery commissioning by June 2026 adds 60 million litres annual capacity.
  • · Jivana brand grew 19% YoY to ₹129 Cr revenue with 7,500+ store reach.
  • · US subsidiary Sathgen Therapeutics is advancing an oral TNBC inhibitor with CDSCO filing targeted for Q2 FY26.
  • · Japanese patent secured for novel antiviral therapy platform.

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 34 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Global High-Priority Regulatory Events

🇺🇸 More from United States

View all →